相关实验视频

Updated: Jan 8, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

胰腺癌精准医学中的补充策略:治疗预测和免疫调节

Wonmin Lee^1,2, Hyun-Myung Woo³, Ja Hyang Cho⁴

¹Translational-Transdisciplinary Research Center, Medical Science Research Institute, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.

Frontiers in oncology

|December 19, 2025

概括

精准医学的进步,包括有机药物查和mRNA疫苗,为胰腺癌 (PDAC) 提供了新的希望. 整合这些技术可能会显著改善患者的治疗结果和生存率.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫治疗是一种免疫疗法.

背景情况:

胰腺管道腺癌 (PDAC) 的5年生存率低于10%,令人丧.
晚期诊断,治疗耐药性和免疫抑制瘤微环境有助于PDAC的致命性.

研究的目的:

审查胰腺管道腺癌的精密医学的最新进展.
分析基于器官的药物查,mRNA免疫疗法和综合诊断技术.

主要方法:

对基于有机体的药物查平台的审查.
对mRNA免疫疗法发展的分析.
对PDAC的综合诊断技术的检查.

主要成果:

患者衍生器官在预测药物敏感性方面显示>80%的一致性.
个性化mRNA新抗原疫苗增强T细胞反应,并延长无复发的生存期.
针对KRAS的疗法在G12C突变PDAC中显示了10-15%的响应率;综合诊断使实时监测成为可能.

结论:

患者衍生器官,mRNA疫苗和精确诊断是PDAC的补充进展.
每种方法都显示出独立的临床价值.
这些技术的整合是改善PDAC结果的关键未来方向.

关键词:

在KRAS突变中发生突变.药物耐药性耐药性药物耐药性免疫疗法免疫疗法在mRNA新抗原疫苗中.胰腺管道腺癌瘤患者获得的有机体精准医学是一门精准医学.

更多相关视频

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...